201320131925-1938.AuthorsTask Force Members Ryden L Grant PJ Anker SD Berne C Cosentino F Danchin N Deaton C Escaned J Hammes HP Huikuri H Marre M Marx N Mellbin L Ostergren J Patrono C Seferovic P Uva MS Taskinen MR Tendera M Tuomilehto J Valensi P Zamorano JL ESC Committee for Practice Guitelines Zamorano JL Achenbach S Baumgartner H Bax JJ Bueno H Dean V Deaton C Erol C Fagard R Ferrari R Hasdai D Hoes AW Kirchhof P Knuuti J Kolh P Lancellotti P Linhart A Nihoyannopoulos P Piepoli MF Ponikowski P Sirnes PA Tamargo JL Tendera M Torbicki A Wijns W Windecker S Document Reviewers De Backer G Sirnes PA Ezquerra EA Avogaro A Badimon L Baranova E Baumgartner H Betteridge J Ceriello A Fagard R Funck-Brentano C Gulba DC Hasdai D Hoes AW Kjekshus JK Knuuti J Kolh P Lev E Mueller C Neyses L Nilsson PM Perk J Ponikowski P Reiner Z Sattar N Schachinger V Scheen A Schirmer H Stromberg A Sudzhaeva S Tamargo JL Viigimaa M Vlachopoulos C Xuereb RG.

2014581513-1518.Li J Zhao F Wang Y Chen J Tao J Tian G Wu S Liu W Cui Q Geng B Zhang W Weldon R Auguste K Yang L Liu X Chen L Yang X Zhu B Cai J.

2013 343035-3087.McMurray JJ Adamopoulos S Anker SD Auricchio A Bohm M Dickstein K Falk V Filippatos G Fonseca C Gomez-Sanchez MA Jaarsma T Kober L Lip GY Maggioni AP Parkhomenko A Pieske BM Popescu BA Ronnevik PK Rutten FH Schwitter J Seferovic P Stepinska J Trindade PT Voors AA Zannad F Zeiher A Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Bax JJ Baumgartner H Ceconi C Dean V Deaton C Fagard R Funck-Brentano C Hasdai D Hoes A Kirchhof P Knuuti J Kolh P McDonagh T Moulin C Popescu BA Reiner Z Sechtem U Sirnes PA Tendera M Torbicki A Vahanian A Windecker S McDonagh T Sechtem U Bonet LA Avraamides PBen Lamin HA Brignole M Coca A Cowburn P Dargie H Elliott P Flachskampf FA Guida GF Hardman S Iung B Merkely B Mueller C Nanas JN Nielsen OW Orn S Parissis JT Ponikowski P Guidelines ESCCfP.

2012 14803-869.Thygesen K Alpert JS White HD Joint ESCACCFAHAWHF Task Force for the Redefinition of Myocardial Infarction Jaffe AS Apple FS Galvani M Katus HA Newby LK Ravkilde J Chaitman B Clemmensen PM Dellborg M Hod H Porela P Underwood R Bax JJ Beller GA Bonow R Van der Wall EE Bassand JP Wijns W Ferguson TB Steg PG Uretsky BF Williams DO Armstrong PW Antman EM Fox KA Hamm CW Ohman EM Simoons ML Poole-Wilson PA Gurfinkel EP Lopez-Sendon JL Pais P Mendis S Zhu JR Wallentin LC Fernandez-Aviles F Fox KM Parkhomenko AN Priori SG Tendera M Voipio- Pulkki LM Vahanian A Camm AJ De Caterina R Dean V Dickstein K Filippatos G Funck-Brentano C Hellemans I Kristensen SD McGregor K Sechtem U Silber S Tendera M Widimsky P Zamorano JL Morais J Brener S Harrington R Morrow D Lim M Martinez-Rios MA Steinhubl S Levine GN Gibler WB Goff D Tubaro M Dudek D Al-Attar N. Universal definition of myocardial infarction.

J Am Heart Assoc.

2017179108-115.Randrianarisoa E Lehn-Stefan A Wang X Hoene M Peter A Heinzmann SS Zhao X Konigsrainer I Konigsrainer A Balletshofer B Machann J Schick F Fritsche A Haring HU Xu G Lehmann R Stefan N. Relationship of serum trimethylamine N-oxide TMAO levels with early atherosclerosis in humans.

N Engl J Med.

Eur Heart J.

2016165 111-124.Michelsen KS Wong MH Shah PK Zhang W Yano J Doherty TM Akira S Rajavashisth TB Arditi M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein e. Proc Natl Acad Sci USA.

201631283-293.Vors C Pineau G Drai J Meugnier E Pesenti S Laville M Laugerette F Malpuech-Brugere C Vidal H Michalski MC.

